161 related articles for article (PubMed ID: 26655276)
21. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.
Chen W; Li M; Cheng H; Yan Z; Cao J; Pan B; Sang W; Wu Q; Zeng L; Li Z; Xu K
Cell Biochem Biophys; 2013; 67(3):1181-91. PubMed ID: 23712865
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.
Ahmed AU; Rolle CE; Tyler MA; Han Y; Sengupta S; Wainwright DA; Balyasnikova IV; Ulasov IV; Lesniak MS
Mol Ther; 2010 Oct; 18(10):1846-56. PubMed ID: 20588259
[TBL] [Abstract][Full Text] [Related]
23. Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus.
Ramachandran M; Yu D; Dyczynski M; Baskaran S; Zhang L; Lulla A; Lulla V; Saul S; Nelander S; Dimberg A; Merits A; Leja-Jarblad J; Essand M
Clin Cancer Res; 2017 Mar; 23(6):1519-1530. PubMed ID: 27637889
[No Abstract] [Full Text] [Related]
24. AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.
Rodríguez-Milla MÁ; Morales-Molina A; Perisé-Barrios AJ; Cejalvo T; García-Castro J
Cancer Gene Ther; 2021 Feb; 28(1-2):64-73. PubMed ID: 32457488
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth.
Hsiao WC; Sung SY; Liao CH; Wu HC; Hsieh CL
Mol Pharm; 2012 May; 9(5):1396-408. PubMed ID: 22480282
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic poliovirus therapy and immunization with poliovirus-infected cell lysate induces potent antitumor immunity against neuroblastoma in vivo.
Toyoda H; Wimmer E; Cello J
Int J Oncol; 2011 Jan; 38(1):81-7. PubMed ID: 21109928
[TBL] [Abstract][Full Text] [Related]
27. In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders.
Hemminki O; Immonen R; Närväinen J; Kipar A; Paasonen J; Jokivarsi KT; Yli-Ollila H; Soininen P; Partanen K; Joensuu T; Parvianen S; Pesonen SK; Koski A; Vähä-Koskela M; Cerullo V; Pesonen S; Gröhn OH; Hemminki A
Int J Cancer; 2014 Jun; 134(12):2878-90. PubMed ID: 24248808
[TBL] [Abstract][Full Text] [Related]
28. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
Stubbendorff M; Deuse T; Hua X; Phan TT; Bieback K; Atkinson K; Eiermann TH; Velden J; Schröder C; Reichenspurner H; Robbins RC; Volk HD; Schrepfer S
Stem Cells Dev; 2013 Oct; 22(19):2619-29. PubMed ID: 23711207
[TBL] [Abstract][Full Text] [Related]
29. Future prospects for oncolytic therapy.
McCormick F
Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
[TBL] [Abstract][Full Text] [Related]
30. Superselective intracerebral catheterization for administration of oncolytic virotherapy in a case of diffuse intrinsic pontine glioma.
Carceller F; Aleu A; Casasco A; Guimaraens L; López-Pino MA; Madero L; Ramírez M
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e430-2. PubMed ID: 24327128
[TBL] [Abstract][Full Text] [Related]
31. A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.
Li JL; Liu HL; Zhang XR; Xu JP; Hu WK; Liang M; Chen SY; Hu F; Chu DT
Gene Ther; 2009 Mar; 16(3):376-82. PubMed ID: 19092859
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
33. Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma.
Franco-Luzón L; González-Murillo Á; Alcántara-Sánchez C; García-García L; Tabasi M; Huertas AL; Chesler L; Ramírez M
Oncotarget; 2020 Jan; 11(4):347-361. PubMed ID: 32064039
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice.
Komorowski M; Tisonczyk J; Kolakowska A; Drozdz R; Kozbor D
Viruses; 2018 Aug; 10(9):. PubMed ID: 30149659
[TBL] [Abstract][Full Text] [Related]
37. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells.
Lien CY; Chih-Yuan Ho K; Lee OK; Blunn GW; Su Y
J Bone Miner Res; 2009 May; 24(5):837-48. PubMed ID: 19113920
[TBL] [Abstract][Full Text] [Related]
38. Oncolytic virotherapy for neuroblastoma.
Ramírez M; García-Castro J; Alemany R
Discov Med; 2010 Nov; 10(54):387-93. PubMed ID: 21122470
[TBL] [Abstract][Full Text] [Related]
39. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
[TBL] [Abstract][Full Text] [Related]
40. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
Bhakta S; Hong P; Koc O
Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
